Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Most Viewed Articles

Advanced Tablet-Coating Technologies Aid Manufacturing Efficiency

June 2, 2012

Pharmaceutical Technology

New coating technologies achieve high uniformity and reduce waste through mixing system advances and pan and airflow configuration.

GMPs for Small-Molecule Drugs in Early Development (Part I)

June 2, 2012

Pharmaceutical Technology

IQ Consortium representatives explore and define common industry approaches and practices for applying GMPs in early development.

Preclinical Dose-Formulation Stability

June 2, 2012

Pharmaceutical Technology

When designing stability protocols, formulation, storage, and dosing conditions must be assessed.

Is Pharma Getting the Best out of Social Media?

June 1, 2012

Pharmaceutical Technology Europe

With social media receiving increased focus as the pharma industry strives to make the most of new communication technologies, we speak with Cognizant's Bhaskar Sambasivan to find out where pharma is when it comes to social media implementation and what more should be being done.

Osiris Therapeutics Announces the World's First Approval of a Stem Cell Therapy

May 30, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Osiris Therapeutics announced that it received marketing authorization from Health Canada to market its stem cell therapy, Prochymal, for the treatment of graft-versus-host disease in children.

Industry Comments on Senate Passage of PDUFA V

May 29, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

The Pharmaceutical Research and Manufacturers of America and Biotechnology Industry Organization released statements last week regarding the Senate's vote to pass the Food and Drug Administration Safety and Innovation Act, which reauthorizes PDUFA.

UK Condemns Parallel Trade

May 24, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

A recent report from the UK's All Party Pharmacy Group has attributed shortages of prescription medicines in the UK to parallel trade and is calling for urgent action.

USP Further Strengthens Heparin Standards

May 23, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

The US Pharmacopeia has issued a third round of improvements to its blood thinner standard.

Human Genome Sciences Rejects GlaxoSmithKline's $2.6 Billion Offer

May 21, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Human Genome Sciences rejects GlaxoSmithKline offer to acquire the company and issues a poison pill to prevent a takeover.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
30%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here